What are neuromuscular disorders?

Neuromuscular disorders encompass a wide range of diseases that affect the voluntary muscles and the nerves that control them.1

They are generally classified depending on the location of involvement, and include:1

Disorders of the muscle (e.g. Duchenne muscular dystrophy)

Disorders of the neuromuscular junction (e.g. congenital myasthenic syndrome)

Disorders of the motor neuron (e.g. spinal muscular atrophy)

Disorders of the peripheral nerve (e.g. Charcot-Marie-Tooth disease)

The majority of neuromuscular disorders that present in childhood have a genetic basis.1 The most commonly encountered genetic paediatric neuromuscular condition is Duchenne muscular dystrophy, which affects 1 out of every 3,600–6000 newborn males worldwide.1-4

What are the signs and symptoms of neuromuscular disorders?

Children with neuromuscular disease experience progressive muscle deterioration and an ongoing decline in physical function.5 The earliest and most common sign of neuromuscular disease is muscle weakness, which manifests as delayed motor development.4,6 Delays in language, speech and cognition should also prompt suspicion that something may be wrong.4,7–9 To learn more about red flag signs and symptoms click here.

Monitoring motor development can help to identify developmental delay earlier, allowing for timely referral to aid the diagnostic process.7

Why early diagnosis matters

Even though neuromuscular diseases are not curable, management and treatment options are available. 10,11

An early diagnosis can facilitate access to the right treatment and services, which may help improve outcomes and help to avoid life-threatening complications. 4,6,10

An early diagnosis can help improve outcomes and avoid life-threatening complications4,6,10 If you suspect a neuromuscular disorder, order a creatine kinase (CK) blood test, click here to learn more.

1. Dowling JJ, et al. Am J Med Genet A. 2018;176:804–841.
2. Goemans N, et al. Eur Neurol Rev. 2014;8:78–82.
3. Bushby K, et al. Lancet Neurol. 2010;9:77–93.
4. van Ruiten HJ, et al. Arch Dis Child. 2014;99:1074–1077.
5. Theadom A, et al. Neuroepidemiology. 2014;43:259–268.
6. Lurio JG, et al. Am Fam Physician. 2015;91:38–44.
7. Noritz GH, et al. Pediatrics. 2013;131:e2016–e2027.
8. Miller N, et al. S Afr J Commun Disord. 2012;59:27–33.
9. Cyrulnik SE, et al. J Pediatr. 2007;150:474–478.
10. Birnkrant DJ, et al. Lancet Neurol. 2018;17(3):251–267 [Part 1].
11. National Task Force for Early Identification of Childhood Neuromuscular Disorders. Child Muscle Weakness. 2019. Available at: www.childmuscleweakness.org [last accessed November 2020].

Our Use of Cookies

In addition to cookies that are necessary to operate this website, we use optional cookies to provide website functionality and give you the best possible experience. We won't set optional cookies unless you enable them. For more detailed information see our Cookie Statement , which explains among others, how to set your cookie preferences and how to recall your consent.

Cookie Settings

Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select the cookie types listed below, and then save your preferences. Refer to our Cookie Statement for more information.

Strictly Necessary cookies
Strictly necessary cookies enable core functionality such as security, network management, and accessibility.

I accept the advertising/targeting cookies
Advertising/targeting cookies, which we use to track user activity and sessions so that we can deliver a more personalized service, and (in the case of advertising cookies) which are set by the third parties with whom we execute advertising campaigns and allow us to provide advertisements relevant to you.